Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women

doi:10.3748/wjg.v20.i44.16726

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 44

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5587)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

385

WORD

137

HTML

2646

Figures (1-2)

146

Tables (1-3)

127

Sum=3441

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

952

Download

1194

Sum=2146

Nov 28, 2014 (publication date) through Apr 29, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Nov 28, 2014; 20(44): 16726-16733
Published online Nov 28, 2014. doi: 10.3748/wjg.v20.i44.16726

Open in New Tab Full Size Figure Download Figure

Figure 1 Trend statement flow diagram. HCV: Hepatitis C virus; AE: Adverse event.

Open in New Tab Full Size Figure Download Figure

Figure 2 Percentage of patients with a sustained virologic response according to prior response to Peginterferon-α + Ribavirin treatment, level of fibrosis and viral load. HCV: Hepatitis C virus; SVR: Sustained virological response.

Citation: Bernabucci V, Ciancio A, Petta S, Karampatou A, Turco L, Strona S, Critelli R, Todesca P, Cerami C, Sagnelli C, Rizzetto M, Cammà C, Villa E. Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women. World J Gastroenterol 2014; 20(44): 16726-16733
URL: https://www.wjgnet.com/1007-9327/full/v20/i44/16726.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i44.16726